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Abstract
Objective—To determine whether hospital differences in the frequency of adverse obstetric
outcomes are related to differences in care.
Study Design—The Assessment of Perinatal EXcellence (APEX) cohort of 115,502 women and
their neonates born in 25 hospitals in the United States between March 2008 and February 2011.
Hierarchical logistic regression was used to quantify the amount of variation in postpartum
hemorrhage, peripartum infection, severe perineal laceration, and a composite adverse neonatal
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outcome among hospitals that is explained by differences in patient characteristics, hospital
characteristics, and the obstetric care provided.
Results—115,502 women were included in the study. For most outcomes, between 20 and 40%
of hospital differences in outcomes were related to differences in patient populations. After
controlling for patient-, provider- and hospital-level factors, multiple care processes were
associated with the predefined adverse outcomes, but these care processes did not explain
significant variation in the frequency of adverse outcomes among hospitals. Ultimately, between
50 and 100% of the inter-hospital variation in outcomes was unexplained.
Conclusion—Hospital differences in the frequency of adverse obstetric outcomes could not be
explained by differences in frequency of types of care provided.
Keywords
obstetrics; quality of care; quality measures
Obstetric admissions are a leading cause of hospitalization in the United States.
Accordingly, there has been an increasing demand for quality measurement from multiple
stakeholders. Quality measures typically take two forms – outcome measures, such as
frequency of peripartum infection, which reflect the actual outcomes that patients have, and
process measures, such as frequency of episiotomy, which reflect adherence to, or avoidance
of, a given type of care.1,2
However, several uncertainties remain about obstetric outcome and process measures and
their ability to represent quality care. There is controversy whether, and to what extent,
hospital differences in outcomes are actually due to differences in the characteristics of their
patient population; correspondingly, case-mix adjustment has been used inconsistently.3,4
Also, there is often an implicit assumption that those hospitals that perform best on process
measures will have the best outcomes as well.5 Yet this assumption has not been proven in
obstetrics.
In fact, there are several potential contributors to the frequency of adverse outcomes,
including patient characteristics (such as maternal age), hospital characteristics (such as the
types of obstetric providers or continual availability of interventional radiology), and the
types of care that are provided (such as the frequency of cesarean delivery). Although poorly
understood, the extent to which each of these categories explains hospital differences in
outcomes is important in determining the adequacy of quality measures. For example, if all
variation in an outcome were due to differences in patient populations, it would make little
sense to use that outcome to represent a hospital’s quality. On the other hand, if much of the
variation in an outcome were not due to differences in patient populations, but differences in
a particular process of care, the use of both specific outcome and process measures would be
better supported.
The specific aim of the present study was to assess whether, and to what extent, hospital
differences in the frequency of adverse obstetric outcomes are related to patient and hospital
characteristics, and to types of care provided.
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The Assessment of Perinatal EXcellence (APEX) study is an observational study designed
to assist in the development of quality measures for intrapartum obstetrical care. This study
was approved by the Institutional Review Board at each participating institution under a
waiver of informed consent. Full details of the study design have been previously
published.6
In summary, patients eligible for data collection were those who delivered on randomly
selected days between March 2008 and February 2011 at any of the 25 hospitals in the
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Maternal-Fetal Medicine Units (MFMU) Network, were at least 23 weeks of gestation, and
had arrived at the hospital with a live fetus. Days were chosen via computer-generated
random selection, with enrollment from larger hospitals limited in order to avoid
overrepresentation of patients from these hospitals. The medical records of all eligible
women and their neonates were abstracted by trained and certified research personnel at the
clinical centers. Patient data that were recorded included demographic characteristics
(including, in order to assess the diversity of the cohort, race and ethnicity as reported in the
chart), details of the medical and obstetrical history, types of intrapartum and postpartum
care, and obstetric outcomes. In addition, characteristics of the providers who cared for the
patients and the hospitals in which they delivered were collected. Maternal data were
collected until discharge and neonatal data were collected until discharge or until 120 days
of age, whichever came first.
Outcomes
The five a priori primary outcomes were 1) venous thromboembolism, 2) postpartum
hemorrhage (PPH), 3) peripartum infection, 4) severe perineal laceration, restricted to
women with vaginal singleton deliveries with no shoulder dystocia, and stratified by
spontaneous (SVD), forceps (FVD) and vacuum (VVD) vaginal delivery, and 5) a
composite neonatal adverse outcome, restricted to term (≥ 37 weeks of gestation), non-
anomalous singleton infants. Additional details regarding the definitions of these outcomes
are detailed elsewhere.6
Statistical Analysis
Sample size for the APEX cohort was based on thromboembolism in cesarean deliveries,
which was expected to have the lowest frequency (0.175% overall and 0.550% in cesarean
deliveries) of the five a priori primary outcomes, using techniques that consider the cluster
design.7,8,9 Assumptions included: 2-sided type I error = 0.01 and the proportion of
deliveries without an associated process measure = 25%. The sample size estimate was
based on 30,000 cesarean deliveries. Conservatively assuming a cesarean frequency of 25%,
a total sample size of 120,000 would enable the detection of an odds ratio of 2.75 for the
association between a process measure and outcome with at least 80% power for the
outcome of thromboembolism. Assuming an odds ratio of 1.5, and event frequencies ranging
from 2.4% to 8.0% for the remaining four outcomes (PPH, peripartum infection, severe
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perineal laceration in vaginal deliveries, and the composite neonatal adverse outcome in
term non-anomalous singletons), power was estimated to range from 83% to 99%; power
was > 99% for these four outcomes assuming an odds ratio of 2.0. Due to fewer than
expected thromboembolism events (0.03% overall) this outcome was not further evaluated.6
For each of the adverse obstetric outcomes, hierarchical logistic regression with hospital
random effects was used to quantify the amount of variation in outcomes among hospitals
that is due to: 1) patient characteristics, 2) provider and hospital characteristics, and 3) the
types of care provided (process measures). The initial regression equation included only the
hospitals as random-effect terms. In each successive stage of the model, another level of
variables – i.e., the patient characteristics, hospital characteristics, or care characteristics –
were added as fixed effects. Per the methods used by Synnes et al,10 each equation
contained a random effects term (bo), and it is the standard deviation (σ) of this term that
serves to quantify the overall variation in outcome frequency across the hospitals. The
difference in the value of σ as each set of characteristics is added to the model then
quantifies the amount of variation between hospitals explained by the additional
characteristics. Odds ratios and 99% confidence intervals (CIs) for each hospital, using the
hospital with the median observed outcome frequency as the referent, were also obtained
from these hierarchical models.
Patient, provider, hospital, and care characteristics eligible for multivariable models were
selected a priori for each outcome based on a plausible association with the outcome (i.e.,
face validity). Details regarding the methods and results for selection of the patient
characteristics has been reported previously.6 The provider and hospital characteristics
eligible for multivariable models included: the specialty of the attending provider, years
since the attending provider graduated from medical/midwifery school, nurse-to-patient ratio
during the shift that delivery occurred, a hospital’s annual delivery volume (expressed in
quartiles), the existence of a prenatal electronic medical record, the occurrence of a
structured review of laboring patients attended by both nursing staff and attending providers,
and the availability of a 24-hour anesthesia service dedicated to the labor and delivery unit.
The presence of a 24-hour in-house attending obstetric provider, a 24-hour in-house
neonatologist or pediatrician, and a 24-hour in-house interventional radiology service also
were evaluated. For each outcome, after the patient characteristics that were previously
selected for risk-adjustment were forced into the model,6 a backwards selection method was
utilized with a P<0.05 to determine which provider and hospital characteristics were to
remain in the regression for each outcome.
After a model that included patient, provider, and hospital characteristics was established,
we examined which types of care (i.e., process measures) provided, selected a priori, were
associated with each outcome. Eligible process measures included: elective delivery prior to
39 weeks of gestation without documented lung maturity, cervical dilation at admission
among women in spontaneous labor, labor induction, proportion of labor with oxytocin
augmentation, maximum dose of oxytocin, duration (minutes) of active stage (5 cm to 10
cm, or 5 cm to cesarean delivery), vaginal exams per hour in the first stage of labor; duration
(minutes) from complete dilation (10 cm) to start of pushing, duration (minutes) from start
of pushing to delivery, vaginal delivery, episiotomy, and type of anesthesia (epidural/
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regional or general). The process measures were individually added to patient and hospital
characteristics-adjusted models that were restricted to women eligible for the type of care
being assessed (e.g., labor induction was not assessed among women with a placenta previa,
as women with this diagnosis would not be eligible to receive induction). In order to
facilitate interpretation, process measures that were initially explored as continuous
variables were dichotomized for use in the final regression model based on clinical
relevance and assessment of plots using a locally weighted scatterplot smoothing technique
(LOESS). Process measures significantly associated with a greater frequency of an adverse
obstetric outcome were identified and used to derive a composite process measure “exposure
score” which was calculated, per the methods by Peterson et al,11 as the proportion of the
care processes that a patient was eligible to receive that were actually received by the
patient. Thus, if a patient received 3 of the 4 care processes significantly associated with the
outcome of interest, her composite exposure was 75%.
SAS software (SAS Institute, Cary, NC), was used for the analyses. All tests were two-
tailed. P<0.01 was used to define statistical significance and 99% CIs were estimated when
directly testing a hypothesis (i.e., examining the association between the process measures
and outcomes) and to identify hospital outliers. P<0.05 and 95% CIs were estimated for
model building and other descriptive analyses.
RESULTS
During the study period, data were collected on 115,502 women and their neonates, as well
as on 1797 different delivery attending providers at 25 hospitals. Characteristics of these
patients, and their providers and hospitals, are provided in Tables 1 and 2. As shown,
women were delivered by a variety of types of providers, and these providers had a range of
experience. Hospital characteristics, including availability of medical services (e.g., obstetric
anesthesia), the presence of electronic medical records, and the attendance of providers at
structured obstetric patient review, varied as well.
The frequencies of the selected outcomes were as follows: PPH 2.29% (95% CI 2.20% –
2.38%), peripartum infection 5.06% (95% CI 4.93% – 5.19%), severe perineal laceration at
SVD 2.16% (95% CI 2.06% – 2.27%), severe perineal laceration at FVD 27.56% (95% CI
25.54% – 29.57%), severe perineal laceration at VVD 14.51% (95% CI 13.34% – 15.67%),
composite neonatal adverse outcome 2.73% (95% CI 2.63% – 2.84%).6 As previously
reported, the frequency of the selected adverse outcomes varied widely and differed
significantly among hospitals (P<0.001 for all).6 The type of care experienced by patients at
different hospitals varied widely as well (Table 3).The frequency of labor induction among
women who were eligible for such an intervention, for example, ranged among hospitals
from 21% to 37%. Oxytocin at rates greater than 20 mU/minute was rarely administered to
laboring women at some hospitals, but this practice occurred in nearly 50% of women who
received oxytocin at other hospitals. There was a more than twenty-fold difference in the
frequency of delayed pushing among women who reached the second stage, and a difference
in the frequency of vaginal delivery that ranged from 61% to 80%. Delivery practices varied
as well, with a 50-fold difference in the frequency of episiotomy among women who had a
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vaginal delivery and more than a ten-fold difference in the use of general anesthesia at
cesarean delivery.
Presented in Table 4 are associations of processes measures (individual and composite
exposure score) with the studied outcomes. Even after controlling for patient, provider and
hospital characteristics, particular types of obstetric care remained associated with the
outcomes of interest.
eFigures 1a – d (Supplement) represent the hospital differences in postpartum hemorrhage
and how those differences are affected by the sequential addition of independent variables in
the different categories (i.e., patient, provider/hospital, and care). For example, eFigure 1a
(Supplement) illustrates the odds ratio for each hospital (identified by the numbers 1 to 25
on the x-axis) for the outcome of PPH derived from the logistic regression model without
any risk-factor adjustment. Hospitals differ significantly from one another (P<0.01) and
some hospitals (represented in red) have significantly higher or lower odds of an outcome
than the reference hospital (i.e. 99% confidence intervals do not include 1.0). If patient,
hospital, and process characteristics are associated with the outcomes, as they are entered
into the regression model, variation among the odds ratios of the hospitals should lessen. If
all variation were explained by these characteristics, the odds ratios associated with each
hospital would be 1.0.
The results of adjusting only for patient characteristics are shown in eFigure 1b
(Supplement), with the results obtained after the further addition of provider/hospital
characteristics shown in eFigure 1c (Supplement). There is a progressive reduction in the
variation of the odds ratios, as illustrated by the hospitals’ odds ratio point estimates that
have “migrated” from their original positions and towards the line representing an “odds
ratio = 1”. However, when care variables are entered into the model, either as a single
variable such as “labor induction” (data not shown) or as a composite exposure score
(eFigure 1d [Supplement]), the odds ratios associated with each hospital are largely
unchanged. Graphical representations for the odds ratios associated with each stage of the
model for the other outcomes are presented in the eFigures 2–6 (Supplement).
Table 5 presents the variation between hospitals (σ) associated with each stage of the
hierarchical logistic regression for each outcome. For infection, none of the inter-hospital
variation was explained by patient characteristics, whereas for the other outcomes between
20 and 40% (% difference between the σs) of the hospital’s variation in outcomes was
related to differences in patient populations. About 20% of the variation in hospital PPH
frequency was related to provider/hospital factors. However for the other outcomes there
was little evidence that inter-hospital outcome variation was related to provider/hospital
factors. In no case did differences in types of obstetric care account for much of the variation
in observed outcomes. Ultimately, between 50 and 100% of the inter-hospital variation in
outcomes was unexplained.
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In this study, we investigated the relationship between differences in obstetric care patterns
and outcomes among hospitals. Several findings are notable. Despite the fact that the
hospitals in the study were either university or university-affiliated and part of a single
research network, the frequencies of obstetric practices were vastly different. After
controlling for differences in patient populations and hospital characteristics, several types
of obstetric care were found to be associated with adverse obstetric outcomes. Nevertheless,
this association did not translate into a capability to explain the hospital differences in
adverse outcomes that were found.
This lack of explanatory power is in contrast to that discerned for care processes in some
other disciplines. For example, Synnes et al10 examined variation in the frequency of
intraventricular hemorrhage among neonates in the intensive care unit. In an analysis similar
to ours, after controlling for patient and hospital factors, they were able to demonstrate that
differences in acidosis treatment, vasopressin use, and surfactant use could account for
differences in inter-hospital rates of intraventricular hemorrhage. Similarly, studying adults
with cardiac disease, Petersen et al11 demonstrated that adherence to particular types of
management (such as beta-blocker use) could explain differences in hospitals’ adjusted-
mortality rates.
Process measures, however, have not been well demonstrated to explain inter-hospital
variation in obstetric outcomes. The inability to do so in the obstetrical population we
studied has implications with regard to obstetric quality measurement and its interpretation.
“Process measures” quantify adherence to a given type of care. Hospitals are often judged
according to their adherence to selected process measures, with the implicit assumption that
the hospitals that perform best on selected measures will have the best health outcomes. Yet,
Draycott et al5 have called attention to the fact that this relationship need not hold. Further,
they cite examples to illustrate that belief in an inexorable relationship between process
measures and outcomes may hinder quality improvement if there is undue focus on process
measures, which may be relatively easy to measure, and less attention paid to actual
outcomes.
Our findings support Draycott et al’s5 contention that although process measures may be
associated with an adverse outcome, the hospitals that perform “best” on those measures, or
combinations of those measures, do not necessarily have the best risk-adjusted rates of
obstetric morbidity. This may be because the labor and delivery process is complex and
dynamic, and the evidence base for “best practice” remains poor. Indeed, the wide variation
in the use of different obstetric practices – starting from the time a woman is admitted,
continuing through her labor, and present at her delivery – are another manifestation of the
lack of consensus for what constitutes best care during many aspects of labor.
These data do not imply that process measurement lacks any value. Process measurement
may provide insight into types of care that hospitals wish to perform more frequently and
may help direct internal improvement initiatives. Also, although we believe we have
selected and analyzed process measures that are most likely to be associated with variation
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in outcomes, there are other process measures that exist and we cannot rule out the
possibility that these unstudied measures would have a relationship with inter-hospital
variation of outcomes. Nevertheless, such relationships have not been demonstrated, and our
findings suggest that the care factors underlying inter-hospital variation in obstetric
outcomes remain poorly understood, and that the practice of ranking individual hospital
obstetric quality based on frequency of adherence to certain process measures may provide
poor insight into which hospitals actually achieve the best outcomes.
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Table 1








≥ 35 19,345 (16.8)
Race/ethnicitya
Non-Hispanic white 52,040 (45.1)
Non-Hispanic black 23,878 (20.7)
Non-Hispanic Asian 5999 (5.2)
Hispanic 27,291 (23.6)
Other 5083 (4.4)
Not documented 1211 (1.1)
Body mass index at delivery,b kg/m2




≥ 40 10,481 (9.3)
Cigarette use during pregnancy 11,370 (9.9)
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No. (%)
Prenatal careb 107,510 (97.9)
Obstetric history
Nulliparous 46,773 (40.5)
Prior vaginal delivery only 49,865 (43.2)
Prior cesarean only 8872 (7.7)
Prior cesarean and vaginal 9963 (8.6)





Anticoagulant use during pregnancy 920 (0.8)
Multiple gestation 2815 (2.4)
Polyhydramnios 940 (0.8)
Oligohydramnios 4700 (4.1)
Placenta previa 467 (0.4)
Placenta accreta 158 (0.1)










Nonbreech malpresentation 931 (0.8)
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No. (%)









≥ 420 654 (0.6)
Birthweight, g
< 2500 12,498 (10.6)
2500–3999 96,708 (81.7)
≥ 4000 9186 (7.8)




Abbreviations: PROM/PPROM = premature rupture of the membranes or preterm premature rupture of the membranes; GBS = group B
streptococcus.
a
Race/ethnicity was reported in the chart;
b
N = 113,167 with body mass index data; N = 109,773 with prenatal care visit data; N = 113,446 with PROM/PPROM data.
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Table 2
Characteristics of the study population’s attending providers and hospitals
No. (%)
Specialty of attending at delivery
General obstetrics and gynecology 84,057 (72.8)
Midwife 7808 (6.8)
Family medicine 3728 (3.2)
Maternal-fetal medicine 18,954 (16.4)
No attending at delivery 859 (0.7)
Years since attending at delivery graduated medical or midwifery school





Nurse-to-patient ratio at deliverya
< 1 31,781 (27.6)
1 – 1.9 58,263 (50.7)
2 – 2.9 15,804 (13.7)
3+ 9160 (8.0)




Patient delivered at hospital with 24-hour in-house obstetric anesthesia service
No 13,150 (11.4)
Yes 102,352 (88.6)
Patient delivered at hospital with 24-hour in-house attending obstetric provider
No 13,823 (12.0)
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No. (%)
Yes 101,679 (88.0)
Patient delivered at hospital with attending providers and/or nurses present for structured obstetric patient reviewb
No obstetricians present at review 21,106 (18.3)
Obstetricians but no nurses present at review 38,052 (32.9)
Both obstetricians and nurses present at review 56,344 (48.8)
Patient delivered at hospital with 24-hour in-house interventional radiology available
No 79,452 (68.8)
Yes 36,050 (31.2)
Patient delivered at hospital with 24-hour in-house attending neonatologist or pediatrician
No neonatologist, no pediatrician 12,532 (10.9)
Pediatrician, no neonatologist 4363 (3.8)
Neonatologist 98,314 (85.3)
a
Total number of nursing hours worked in L&D during the 8-hour shift divided by 8, divided by the numbe of patient admissions during the 8-hour
shift;
b
Official board sign-out at shift change or other structured patient review.
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Table 3
Observed hospital frequencies of types of obstetric care
Lowest Percent Median Percent Highest Percent
Labor inductiona 20.8 28.2 37.1
Dilation ≤ 2 cm at admissionb 6.6 13.6 25.9
Maximum oxytocin ≥ 20 mU/minutec 8.7 17.6 46.3
≥ 80% of labor augmented with oxytocind 1.0 10.1 22.6
≥ 1 hour between complete dilation and initiation of pushinge 0.8 10.9 21.2
≥ 2 hours between initiation of pushing to deliverye 4.4 9.1 19.2
≥ 8 hours active phasef 2.9 8.3 19.2
< 1 vaginal exam per every 3 hours in first stageg 2.9 21.0 43.7
Vaginal deliveryh 60.6 70.1 79.5
Episiotomyi 0.7 7.0 35.4
Epidural/regional anesthesiaj 45.3 77.7 89.7
General anesthesiak 1.1 6.5 14.8
Elective delivery < 39 weeks without documented fetal lung maturityl 0.2 0.5 12.2
a
In patients with no previa and no history of classical, T, or J cesarean (N = 113,049);
b
In patients at term with intact membranes and spontaneous intended labor with no previa and cervical dilation measured within one hour before or
after L&D admission (N = 46,068);
c
In patients who received oxytocin in labor (N = 58,228);
d
In patients with spontaneous intended labor admitted to L&D before delivery (N = 61,157);
e
In patients who reached complete after intended labor (N = 60,290);
f
In patients with intended labor who reached active stage (5 cm) with a term non-anomalous singleton pregnancy (N = 71,571);
g
In patients with intended labor managed in hospital for greater than 1 hour during first stage (N = 81,826);
h
In all patients (N = 115,502);
i
In patients with a vaginal delivery and no shoulder dystocia (N = 77,071);
j
In patients with non-operative vaginal delivery of a singleton, no shoulder dystocia and reached complete after intended labor (N = 70,362);
k
In patients with a cesarean delivery (N = 36,201);
l
In patients with a term non-anomalous singleton pregnancy (N = 98,509).
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